This Health Affairs article presents differences in outcomes between Medicare Care Choices Model enrollees that received treatment for terminal conditions along with supportive and palliative care and matched comparison beneficiaries who received usual services covered by original Medicare.
This is the final report on the evaluation of the Medicare Care Choices Model, which tested offering eligible beneficiaries the option to receive supportive and palliative care services through hospice providers without forgoing payment for the treatment of their terminal conditions.
Clinical guidelines or guidance is an important tool for preventing and treating antimicrobial-resistant (AMR) infections.
The Findings at a Glance provides a brief overview of key findings from the independent evaluation of the first four years of CPC+, for practices that began the model in 2017.
The Fourth Annual Report presents findings from the independent evaluation of the first four years of CPC+ for practices that began the model in 2017. The report examines CPC+ participation, supports, implementation, and impacts.
Evaluation of the Medicare Care Choices Model’s effects on beneficiaries’ outcomes from January 2016 to March 2021.
This study introduces two new claims‐based measures to assess quality of care during a patient's vulnerable period following acute care.
The Third Annual Report presents findings from the independent evaluation of the first three years of CPC+ for practices that began the model in 2017. The report examines CPC+ participation, supports, implementation, and impacts.
The authors analysis represents rigorous estimates of the hospital costs of a variety of inpatient harms; these should be of interest to health care administrators and policy makers to identify areas for cost savings to the health care system.
This is an interim evaluation report for the Partnership for Patients (PfP) campaign. The goals of the evaluation were to assess the reduction in inpatient harms and readmissions during the period 2011–2014, and to assess, if possible, the contribution that PfP made to those reductions.
The goal of the evaluation is to assess the harm reduction during the period when all three engines (CMMI, federal partners, and private partners) were engaged simultaneously in an extraordinary effort to meet the common goals.
The goal of the evaluation is to assess the harm reduction during the period when all three engines (CMMI, federal partners, and private partners) were engaged simultaneously in an extraordinary effort to meet the common goals.
This book chapter looks at the CMS-funded Informatics for Diabetes Education and Telemedicine demonstration.
Home telemedicine holds promise for cost-effective delivery of monitoring, educational, and therapeutic services to people with chronic illnesses.
Presents findings from the third report to Congress on the Medicare Coordinated Care Demonstration.
Beneficiaries with chronic diseases account for nearly two-thirds of all Medicare expenditures.